We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+4.67%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.05B
AUM Growth
+$276M
(+4.1%)
Cap. Flow
+$73M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
27.96%
Holding
1,430
New
433
Increased
334
Reduced
305
Closed
319
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$182M |
| 2 |
ENDP
Endo International plc
ENDP
|
+$170M |
| 3 |
AET
Aetna Inc
AET
|
+$131M |
| 4 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
+$108M |
| 5 |
Brookdale Senior Living
BKD
|
+$91.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$435M |
| 2 |
Elevance Health
ELV
|
+$121M |
| 3 |
Cigna
CI
|
+$119M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
+$82.7M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$72.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 49.34% |
| 2 | Financials | 7.86% |
| 3 | Consumer Discretionary | 7.17% |
| 4 | Technology | 6.32% |
| 5 | Industrials | 4.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
International Flavors & Fragrances
IFF
$20.2B
| $256K | ﹤0.01% |
2,338
-17,662
| -88% | -$2.04M |
|
852
Regal Rexnord
RRX
$13.7B
| $256K | ﹤0.01% |
+3,524
| New | +$272K |
|
|
WP
853
DELISTED
Worldpay, Inc.
WP
| $256K | ﹤0.01% |
+6,698
| New | +$266K |
|
854
SBA Communications
SBAC
$19.2B
| $255K | ﹤0.01% |
+2,220
| New | +$261K |
|
855
International Paper
IP
$21.6B
| $254K | ﹤0.01% |
5,643
-1,028
| -15% | -$51K |
|
856
Wabtec
WAB
$49.1B
| $254K | ﹤0.01% |
2,700
-68,436
| -96% | -$6.72M |
|
|
CERN
857
DELISTED
Cerner Corp
CERN
| $254K | ﹤0.01% |
+3,680
| New | +$258K |
|
858
Designer Brands
DBI
$307M
| $253K | ﹤0.01% |
+7,578
| New | +$271K |
|
|
MSCC
859
DELISTED
Microsemi Corp
MSCC
| $253K | ﹤0.01% |
+7,232
| New | +$254K |
|
860
Alaska Air
ALK
$5.29B
| $252K | ﹤0.01% |
3,906
-5,829
| -60% | -$376K |
|
861
Church & Dwight Co
CHD
$23.4B
| $252K | ﹤0.01% |
+6,200
| New | +$260K |
|
862
Littelfuse
LFUS
$11.2B
| $252K | ﹤0.01% |
2,651
-3,240
| -55% | -$316K |
|
|
KRFT
863
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
| $252K | ﹤0.01% |
+2,960
| New | +$255K |
|
864
Flowers Foods
FLO
$1.49B
| $251K | ﹤0.01% |
11,856
-62
| -0.5% | -$1.39K |
|
865
Ingles Markets
IMKTA
$1.71B
| $251K | ﹤0.01% |
+5,261
| New | +$254K |
|
|
FINL
866
DELISTED
Finish Line
FINL
| $250K | ﹤0.01% |
+9,000
| New | +$233K |
|
867
Sensient Technologies
SXT
$5.26B
| $249K | ﹤0.01% |
+3,642
| New | +$247K |
|
868
Darling Ingredients
DAR
$9.64B
| $248K | ﹤0.01% |
+16,885
| New | +$249K |
|
869
Ameren
AEE
$30.3B
| $247K | ﹤0.01% |
6,547
-1,638
| -20% | -$65.8K |
|
|
WCG
870
DELISTED
Wellcare Health Plans, Inc.
WCG
| $247K | ﹤0.01% |
+2,912
| New | +$246K |
|
871
PPG Industries
PPG
$24.6B
| $246K | ﹤0.01% |
+2,142
| New | +$245K |
|
872
LiveRamp
RAMP
$2.3B
| $246K | ﹤0.01% |
+13,990
| New | +$251K |
|
|
KS
873
DELISTED
KapStone Paper and Pack Corp.
KS
| $246K | ﹤0.01% |
10,620
-8,470
| -44% | -$234K |
|
|
PMC
874
DELISTED
PharMerica Corporation
PMC
| $246K | ﹤0.01% |
+7,400
| New | +$227K |
|
875
PUT
SPDR Gold Trust
GLD
$131B
| $245K | ﹤0.01% |
+1,500
| New | +$172K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q2 2015 Portfolio in Review
As of Q2 2015, Visium Asset Management held 1,430 positions worth $7.05B, up 4.1% from $6.78B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Visium Asset Management's Q2 2015 filing shows 433 new, 334 increased, 305 reduced and 319 closed positions. Its largest new stake was Sio Gene Therapies Inc. Common Stock: 635,000 shares worth $104M. The largest sale was Allergan plc, an estimated $435M.
By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
- Visium Asset Management's largest Q2 2015 buy was Sio Gene Therapies Inc. Common Stock: 635,000 shares worth $104M.
- Visium Asset Management added most to Bausch Health in Q2 2015, an estimated $182M increase.
- Visium Asset Management's biggest Q2 2015 reduction was Elevance Health, cutting an estimated $121M.
- Visium Asset Management fully exited Allergan plc in Q2 2015, selling an estimated $435M.
- Visium Asset Management's ten largest holdings make up 28% of its $7.05B portfolio in Q2 2015.
- Visium Asset Management opened 433 new positions and closed 319 in Q2 2015.
- Visium Asset Management's portfolio value rose 4.1% quarter-over-quarter to $7.05B.
Based on Visium Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.